B. Riley Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

B. Riley Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-375	Closed	-$21K	–	433
2015 Q2	$21K	Hold	375	–	–	0.02%	592
2015 Q1	$21K	Hold	375	–	–	0.02%	597
2014 Q4	$18K	Hold	375	–	–	0.01%	608
2014 Q3	$17K	Hold	375	–	–	0.01%	651
2014 Q2	$16K	Hold	375	–	–	0.01%	714
2014 Q1	$16K	Buy	+375	New	+$15.7K	0.01%	669

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

B. Riley Wealth Management's IHE Position: Q3 2015 in Review

B. Riley Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 375 shares — an estimated $21K sold.

B. Riley Wealth Management first reported a position in IHE in Q1 2014 and held it in 6 quarters. The position peaked at $21K in Q2 2015. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

B. Riley Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
B. Riley Wealth Management sold 375 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $21K.
B. Riley Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 6 quarters.
B. Riley Wealth Management's iShares US Pharmaceuticals ETF position peaked at $21K in Q2 2015.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.